-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Mersana Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2016 to Q3 2024.
- Mersana Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.09 USD/shares, a 74.3% increase year-over-year.
- Mersana Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.59 USD/shares, a 66.7% increase year-over-year.
- Mersana Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.48 USD/shares, a 32.1% increase from 2022.
- Mersana Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.18 USD/shares, a 9.54% increase from 2021.
- Mersana Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -2.41 USD/shares, a 68.5% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)